
DMSO: A Natural Compound's Potential in Cancer Treatment - AI Podcast
May 2, 2025
Discover the remarkable versatility of dimethyl sulfoxide (DMSO) as a therapeutic agent in cancer treatment. It offers protective benefits for healthy cells while enhancing chemotherapy effectiveness. With the ability to improve drug delivery and permit lower doses, DMSO significantly reduces toxic side effects. Explore its synergy with other pharmaceutical agents and promising applications in photodynamic therapy for skin cancers. The podcast also addresses the barriers DMSO faces in gaining wider acceptance in oncology, urging the need for innovative approaches in its use.
AI Snips
Chapters
Transcript
Episode notes
Historic Study Shows Remission Success
- In a 1975 study, 57 of 65 incurable cancer patients saw remission with low-dose cyclophosphamide in DMSO.
- Patients intolerant before tolerated treatment well, showing DMSO's cell-protective effect.
Oral DMSO Enhances Drug Potency
- Oral DMSO enhances multiple chemotherapy drugs, boosting survival without added toxicity in animal models.
- It raises systemic drug levels briefly, delivering focused tumor assaults while sparing healthy tissue.
DMSO Breaks Blood-Brain Barrier
- DMSO crosses the blood-brain barrier reaching brain tumors at 1.5 times normal tissue levels.
- Combining it with chemotherapy achieves deeper penetration and tumor shrinkage in gliomas where standard methods fail.
